Training people with diabetes to teach other patients improves utilization of medications and results in lifestyle changes….
Read More »Diabetes In Control
ADA: Vascular Status Predicts Hypoglycemia
Type 2 diabetes patients with microvascular or macrovascular complications, or those taking certain monotherapies, are more likely to experience hypoglycemia and require outpatient hospital visits….
Read More »ADA: Even Diet Soda Induces Weight Gain in the Elderly
The perception that diet soft drinks are a benign alternative to highly sweetened beverages might be dangerously wrong….
Read More »ADA: Intensive Therapy Yields Negligible Benefits in Type 2 Diabetes
In patients diagnosed with type 2 diabetes through screening in general practice, intensive multifactorial treatment improved cardiovascular risk factors, compared with usual care, new findings suggest, but those improvements were very small.…
Read More »ADA: Higher Vitamin D Levels Linked to Lower Diabetes Risk
Higher levels of vitamin D in the blood appear to be associated with a reduced risk for incident diabetes among people at high risk for the disease.…
Read More »ADA: TAK-875 a Novel Agent in the Treatment of Type 2 Diabetes
Takeda Pharmaceuticals recently completed a Phase 2 study with its novel anti-diabetic agent TAK-875, which could help lead to more individualized patient care and diabetes management….
Read More »ADA: Restoring Visual Acuity in Diabetes with VEGF Inhibitor
The vascular endothelial growth factor (VEGF) inhibitor ranibizumab (Lucentis) proves promising in treating diabetic macular edema….
Read More »Letter from the Editor: We Bring You the Best of the ADA
Steve and Andrew came home with tons of new information from the recent ADA 71st Scientific Sessions. We are going to be sharing the information with you for the next couple of weeks as we continue to review and evaluate the articles and studies. There are articles on new classes …
Read More »ADA: Public Knows about Diabetes, Yet Takes No Action
Americans are well informed about the risks, dangers, and signs of diabetes, but that knowledge does not appear to translate into actions to prevent or control the disease, researchers reported. Almost 87% of the 3,867 type 2 diabetes respondents in a huge national sampling knew that obesity contributes to chronic …
Read More »ADA: Tiny Pump Helps Improve Glycemic Control
A matchstick-sized implantable subcutaneous pump that delivers a steady flow of the GLP-1 agonist exenatide (Byetta) maintained improvements in glycemic control over a year, researchers said. The purpose is to increase adherence, while offering greater efficacy and reduced side effects. The pump has to be inserted every three months, but …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.